2.7. Ethical Considerations
cognitive impairment
The study (identity number: AFU-PPG-2017-01) was approved by the Clinical Research Ethics Committee of the Gipuzkoa Health Area. Informed consent was previously obtained from all recruited patients. In cases where participants had cognitive impairment, consent was obtained from legal guardians who acted as surrogate informants.